Novo Nordisk Lifts 2026 Guidance to +2% to -2%

Novo Nordisk raised its 2026 adjusted sales and operating profit guidance, its own forecast, to +2% to -2% on November 4, after third-quarter profit beat forecasts, Reuters reported. The range straddles zero, meaning it spans both growth and decline. In February it forecast a decline of up to 13%. In May, it said the worst drop would likely be 12%.